← FDA Drug Approvals (Drugs@FDA)

ANDA205902

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 2018-12-13

Drug application

FDA Application #

ANDA205902

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

WATSON LABS

First approval

2018-12-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown